| |
|
|
|
Arcus Biosciences Inc  
|
|
29.05 -1 (-0.03%) |
06-05 16:00 |
|
Open: |
30.67 |
Pre close: |
30.05 |
Target:
|
38.30
|
|
High: |
30.7037 |
Low: |
28.08 |
Resistance:
|
32.79
37.41
|
|
Volume: |
845,292 |
Market Cap: |
1338M |
Support:
|
25.31
21.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
31.57
 |
MACD |
MACD(12,26):
|
1.13 |
|
MA(20): |
32.10 |
Signal(12,26,9): |
1.93 |
|
MA(100): |
19.39  |
Stochastic Oscillator |
%K(14,3):
|
32.50 |
|
MA(250): |
12.76 |
%D(3): |
46.79 |
|
Average Volume(K) |
3-Month: |
76396
|
52-Week |
High:
|
37.41 |
|
10-Days: |
133582 |
Low: |
6.30 |
|
RSI |
RSI(14):
|
47.71 |
Change(%): |
262.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.150 |
Return on Equity (ttm) |
-52.3 |
Shares Out. (M) |
46.05 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-28.3 |
Shares Float (M) |
25.98 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.97 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
53.08 |
|
Forward EPS |
-1.930 |
Gross Profit (p.s.) |
-1.379 |
Shares Short (K) |
332 |
|
Book Value (p.s.) |
3.060 |
EBITDA (p.s.) |
-2.060 |
P/E |
-13.51 |
|
Sales Per Share |
0.326 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.49 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-87.90 |
P/S |
89.18 |
|
Operating Margin |
-655.57 |
Levered Free Cash Flow
(M) |
-52.00 |
P/CF |
-15.22 |
|
|
|
|
|
|
